Claudia Denkinger

Prof. Claudia Denkinger is a renowned academic at Heidelberg University, holding the position of Medical Director and Professor in the Department of Infectious and Tropical Medicine. She leads the AG Global DX research group and has spearheaded global health initiatives, particularly in tuberculosis (TB) diagnostics and antimicrobial resistance. Her work bridges clinical research, public health policy, and innovative diagnostic technologies.

• Roles: Professor, Medical Director at Heidelberg University Hospital
• Affiliations: Medical Faculty of Heidelberg University, Foundation for Innovative New Diagnostics (FIND)

Her research focuses on advancing TB diagnostics, host biomarkers, and global health equity. Notable contributions include developing non-sputum-based TB tests (e.g., tongue swab diagnostics) and evaluating molecular tools like Xpert MTB/RIF. She has pioneered collaborations with institutions worldwide to address TB drug resistance and public health challenges.

Key awards include the Gertrud Meissner Award (2008) for mycobacteriology contributions and the Memento Preis (2018) from Médecins Sans Frontières. Her career spans leadership roles at Harvard Medical School, McGill University, and the University of Tübingen, reflecting a commitment to translational research and global health impact.

Publications emphasize diagnostic accuracy studies, biomarker development, and policy-relevant analyses, often involving multi-country trials to ensure practical applications in resource-limited settings.